Establishment of an intermediate healthcare holding company and consolidation of ソラミチシステム
First written in FY2021-Q2. 4 of 7 entries say "Advanced", first in FY2021-Q3. Latest entry: 2026-08-06.
5 other companies' latest entry also says "Advanced".
- FY2023RestatedAnnual report
「The 母子モ business is being introduced by municipalities nationwide through cooperation with MEDIPAL HOLDINGS CORPORATION, and the rollout of child-rearing DX is also progressing smoothly. The business is intended to be integrated into MTI Healthcare Holdings Co., Ltd. as a business with a high degree of cooperation with MEDIPAL HOLDINGS CORPORATION.」
The 母子モ business continues to be consolidated under the healthcare intermediate holding company, based on an organisational structure premised on cooperation with MEDIPAL. - FY2023-Q1AdvancedAnnual report
「The Moshimo business has expanded installations in municipalities nationwide through collaboration with MEDIPAL HOLDINGS CORPORATION, and the rollout of child-rearing DX has also progressed steadily. The company aims to integrate the business into MTI-HC-HD as a business with a high degree of collaboration with MEDIPAL HOLDINGS CORPORATION.」
The scope of businesses to be consolidated under the healthcare intermediate holding company expanded from ソラミチシステム and others to the 母子モ business, and part of the 母子モ shares was transferred on 20 October 2022. - FY2021AchievedAnnual report
「On 1 July 2021, we established MTI Healthcare Holdings Co., Ltd. as an intermediate holding company for our healthcare business through a sole-share transfer by our consolidated subsidiary 株式会社カラダメディカ.」
The planned healthcare intermediate holding company was established on 1 July 2021, and the shares of ソラミチシステム were consolidated under the company on 31 August. The organisational restructuring reached the implementation stage. - FY2021-Q3AdvancedAnnual report
「On 1 July 2021, we established MTI Healthcare Holdings Co., Ltd. as an intermediate holding company for our healthcare business through a sole-share transfer by our consolidated subsidiary 株式会社カラダメディカ. On the same date, we transferred the business related to LunaLuna Medico, a medical support service for gynecology and obstetrics and gynecology clinics that forms part of our healthcare business, to our wholly owned subsidiary 株式会社ルナルナメディコ through a company split (simplified absorption-type company split).」
The planned healthcare intermediate holding company was established on 1 July 2021, and the company split of the LunaLuna Medico-related business was also carried out on the same date. The policy of progressively consolidating businesses with a high degree of cooperation with MEDIPAL into the intermediate holding company is advancing into concrete organisational restructuring. - FY2021-Q2First statedAnnual report
「The company determined that, from the perspective of promoting closer and more agile collaboration, it would be effective to establish an intermediate holding company and consolidate the businesses in which the two companies have a high degree of collaboration. “1 July 2021 (planned): establishment of MTI-HC-HD”; “31 August 2021 (planned): distribution of all common shares of ソラミチシステム from 株式会社カラダメディカ to MTI-HC-HD.”」
The company first disclosed an organisational restructuring plan, approved on 12 May 2021, to establish 株式会社エムティーアイ・ヘルスケア・ホールディングス and consolidate ソラミチシステム under its umbrella through カラダメディカ.